---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-006678"
form_type: "8-K"
ticker: "ANIK"
cik: "0000898437"
company_name: "Anika Therapeutics, Inc."
filed_at: "2023-11-02T23:59:59+00:00"
generated_at: "2026-06-09T01:31:20.969663+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Anika Q3 revenue $41.5M (+3% YoY); raises FY2023 guidance to $164-166M

## Summary
- Revenue $41.5M (+3% YoY); Joint Preservation & Restoration up 14% to $13.5M, OA Pain Mgmt up 2% to $24.9M.
- Net loss ($6.6M), ($0.45)/share; adjusted net income $0.00/diluted share; includes $4.2M software charge.
- Adjusted EBITDA $4.7M vs $4.1M; cash from ops $6.5M, cash $70.7M.
- Raised FY2023 revenue guidance to $164-166M (from $159.5-163M), implying 5-6% growth.
- FDA cleared Integrity Implant System (rotator cuff patch) and X-Twist biocomposite; launches Q1 2024.

## SEC filing metadata
- accession: 0001171843-23-006678
- form_type: 8-K
- ticker: ANIK
- cik: 0000898437
- company_name: Anika Therapeutics, Inc.
- filed_at: 2023-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/898437/000117184323006678/0001171843-23-006678-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/898437/000117184323006678/f8k_110223.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-006678
- JSON: https://secwatch.observer/filing/0001171843-23-006678.json
- Plain text: https://secwatch.observer/filing/0001171843-23-006678.txt

## Key facts
- Earnings Releases
  Anika Therapeutics, Inc. updated its the third quarter ended September 30, 2023 guidance (raised).
  - Period: the third quarter ended September 30, 2023
  - Guidance: raised
  - Result: reported results
  source text: On November 2, 2023, Anika Therapeutics, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/898437/000117184323006678/0001171843-23-006678-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.